Lacrimal gland lymphoma: Role of radiation therapy.

Oman Journal of Ophthalmology
Natasha TownsendMitchell R Smith

Abstract

To report the clinical and treatment outcome of patients with lacrimal gland lymphoma (LGL) treated with radiation therapy (RT) at Fox Chase Cancer Center, Philadelphia, PA, USA. Institutional review board approved retrospective chart review of eight patients and literature review. The study patients included six males and two females with a mean age of 70 years (range 58-88 years). The mean follow-up period was 23 months (range 3-74 months). Four patients had mucosa-associated lymphoid tissue (50%) lymphoma and four patients had other non-Hodgkin's lymphoma variants. Four patients had bilateral disease (50%). Four patients had primary LGL (stages I-IIAE, 50%) and four had LGL as part of systemic lymphoma (stage IVAE, 50%). The median RT dose was 2987 cGy (range 2880-3015 cGy). All patients had complete response to RT with symptomatic relief. Minimal dry eye was seen in all patients. There were no late effects such as corneal ulcer, radiation retinopathy, maculopathy, papillopathy, or secondary neovascular glaucoma. RT alone is an extremely effective treatment in the curative management of localized LGL and provides durable, local control of secondary LGL.

References

Mar 30, 1995·International Journal of Radiation Oncology, Biology, Physics·P RubinT H Wasserman
Feb 15, 1995·International Journal of Radiation Oncology, Biology, Physics·C K ChaoM Smith
Apr 30, 1993·International Journal of Radiation Oncology, Biology, Physics·M C Smitt, S S Donaldson
Apr 29, 1999·International Journal of Radiation Oncology, Biology, Physics·T W BolekN P Mendenhall
Apr 28, 2001·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·S L StaffordT M Habermann
Dec 6, 2005·Virchows Archiv : an International Journal of Pathology·Annette ZimpferAlexandar Tzankov
Dec 23, 2006·American Journal of Ophthalmology·Shu-Ching KaoWen-Ming Hsu
Mar 26, 2008·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Sharad GoyalVenkat Narra
Apr 9, 2008·Investigative Ophthalmology & Visual Science·Lene D SjöSteffen Heegaard
May 12, 2009·The British Journal of Ophthalmology·P RasmussenS Heegaard
Oct 12, 2011·Archives of Ophthalmology·Peter RasmussenSteffen Heegaard

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
flow cytology

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Related Papers

International Journal of Radiation Oncology, Biology, Physics
M Raphael PfefferZvi Symon
International Journal of Radiation Oncology, Biology, Physics
Sudershan BhatiaB-Chen Wen
International Journal of Radiation Oncology, Biology, Physics
Ping ZhouPeter M Mauch
International Journal of Radiation Oncology, Biology, Physics
Chang-Ok SuhJee Sook Hahn
© 2021 Meta ULC. All rights reserved